It has been reported that sensitivity to angiotensin II (Ang II) is higher in efferent (Ef) than afferent (Af) arterioles (Arts). We tested the hypothesis that this is due to arteriolar differences in the interaction between Ang II and endothelium-derived relaxing factor/nitric oxide (EDNO). Rabbit Af-Arts with glomerulus intact were microperfused in vitro at a constant pressure. Ef-Arts were perfused from the distal end of either the Af-Art (orthograde perfusion) or the Ef-Art (retrograde perfusion) to eliminate influences of the Af-Art or glomerulus, respectively. Ang II did not alter Af-Art luminal diameter until the concentration reached 10-9 M, which decreased the diameter by 11±2.6% (n = 11; P < 0.002). In contrast, Ef-Arts became significantly constricted at concentrations as low as 10-11 M with either perfusion. Surprisingly, the decrease in Ef-Art diameter at 10-10, 10-', and 10-8 M was significantly greater with retrograde perfusion (44±6.9%, 70±5.6%, and 74±4.1%, respectively; n = 5) than with orthograde perfusion (16±4.2%, 25±2.9%, and 35±3.5%; n = 9). ENDO synthesis inhibition with 10-4 M nitro-L-arginine methyl ester (L-NAME) decreased the diameter to a greater extent in Af-Arts (22±3.0%; n = 11 ) compared to Ef-Arts with either orthograde (9.5±2.3%; n = 8) or retrograde perfusion (1.2±2.1%; n = 6). With L-NAME pretreatment, Af-Art constriction induced by 10-10 M (14±4.0%, n = 9) and 10-9 M Ang 11 (38±3.9%) was significantly greater compared to nontreated Af-Arts. In contrast, L-NAME pretreatment had no effect on Ang II-induced constriction in Ef-Arts with either perfusion. In conclusion, this study demonstrates higher sensitivity of Ef-Arts to Ang II, particularly with retrograde perfusion. Our results suggest that EDNO significantly modulates the vasoconstrictor action of Ang II in Af-Arts II but not Ef-Arts, contributing to the differential sensitivity
Introduction
The renin-angiotensin system plays an important role in the regulation of blood pressure, homeostasis of fluid volume and electrolytes, and pathogenesis of various forms of hyperten-sion. A number of studies have examined the role ofangiotensin II (Ang II), ' the physiologically active component of the system, in the control ofrenal hemodynamics as well as its sites ofaction within the kidney ( 1 ). Infusion ofAng II or inhibition of its action in the kidney has been shown to result in an increased or decreased filtration fraction, respectively (2) (3) (4) (5) . Thus it has been postulated that sensitivity to Ang II is higher in the postglomerular efferent (Ef) than in the preglomerular afferent (Af) arteriole (Art). Although recent studies using isolated microvessels have demonstrated higher sensitivity of the Ef-Art (6, 7) , the mechanism(s) responsible for this difference in sensitivity is (are) not well understood.
We have recently shown that in isolated microperfused rabbit Af-Arts, inhibition of endothelium-derived relaxing factor/ nitric oxide (EDNO) not only reduces basal luminal diameter but also augments the vasoconstrictor action of Ang II (8) . This suggests that EDNO, which is produced locally in the Af-Art, is an important autacoid hormone that controls vascular reactivity. Although studies have shown that endogenous EDNO plays an important role in the control ofrenal hemodynamics (9) , it is not known whether either activity ofEDNO or its interaction with other vasoactive substances differs between the Af-Art and Ef-Art. Since the Af-Art and Ef-Art are crucial vascular segments that control glomerular hemodynamics (and hence renal excretory function), it would be important to understand the action of EDNO in these vessels.
In the present study, we tested the hypothesis that endogenous EDNO modulates Ang II action to a greater extent in the Af-Art than in the Ef-Art, contributing to the difference in sensitivity to Ang II. For this, we microdissected and perfused rabbit Af-Arts and Ef-Arts in vitro and studied whether (a) response to EDNO inhibition or (b) EDNO modulation of Ang II action is different between the two vessels.
Methods
Isolation and microperfusion ofthe rabbit Af-and Ef-Art
We used a method similar to that described previously to isolate and microperfuse Af-Arts (8, 10) . Briefly, young male New Zealand white rabbits ( 1.5-2.0 kg), fed standard rabbit Chow (Ralston Purina Co., St. Louis, MO) and tap water ad lib., were anesthetized with intravenous sodium pentobarbital (40 mg/kg) and given an intravenous injection of heparin (500 U). The kidneys were removed and sliced along the corticomedullary axis. Slices were placed in ice-cold MEM (Gibco Laboratories, Grand Island, NY) containing 5% BSA (Sigma Chemical Co., St. Louis, MO) and dissected under a stereomicroscope (model SZH; Olympus Corp., Tokyo, Japan) as described previously. From 1. Abbreviations used in this paper: Af-Art and Ef-Art, afferent and efferent arteriole, respectively; Ang II, angiotensin II; EDNO, endothelium-derived relaxing factor/nitric oxide; L-NAME, nitro-L-arginine methyl ester; NE, norepinephrine. each rabbit, a single superficial Af-Art with its glomerulus intact was microdissected. Using a micropipette, the Af-Art was transferred to a temperature-regulated chamber mounted on an inverted microscope (model IMT-2; Olympus Corp.) with Hoffman modulation. The AfArt was then cannulated with an array of glass pipettes as described previously (8, 10) . Intraluminal pressure was measured by Landis' technique, using a fine pipette introduced into the arteriole through the perfusion pipette. This technique was used because it has been reported that pressure measurement by a servo-null system is not accurate with our arrangement of pipettes. The arteriole was perfused with oxygenated medium 199 containing 5% BSA, and intraluminal pressure was maintained at 60 mmHg throughout the experiment.
We employed two approaches to study Ef-Art, namely orthograde and retrograde perfusion. For orthograde perfusion, a short (-50 Mm)
Af-Art with its glomerulus intact and a segment ofthe attached Ef-Art (250-300 Mm) were microdissected. The Af-Art was cannulated as described above, except that the perfusion pipette was advanced to the end of the Af-Art (Fig. 1, top 3. Inhibition ofEDNO synthesis with nitro-L-arginine methyl ester (L-NAME). After the equilibration period, increasing doses of L-NAME ( l0-7 to l0-4 M; Sigma Chemical Co.), a compound that inhibits EDNO synthesis ( I I ), were added to the lumen. Luminal diameter was measured immediately before adding L-NAME and observed for at least 15 min at each dose.
4. Effect of L-or D-arginine on L-NAME-induced constriction. We examined whether Af-Art vasoconstriction induced by L-NAME is specifically due to inhibition of EDNO synthesis from L-arginine ( 12) . We first inhibited EDNO synthesis with L-NAME at l0-4 M, after which either L-arginine or its inactive isomer D-arginine at 10-' M (Sigma Chemical Co.) was added to the lumen together with L-NAME. 5 . Effect of L-NAME on Ang II-induced vasoconstriction. After the equilibration period, l0-4 M L-NAME was added to the arteriolar perfusate. Fifteen minutes later, the effect of Ang II was examined as in protocol 1. We have previously shown that L-NAME at this concentration blocks acetylcholine-induced vasodilation in Af-Arts preconstricted with NE (8) . We have also confirmed that L-NAME is just as effective in the Ef-Art. The Ef-Arts were preconstricted with NE (5 x 10-7 M) to 82±3.6% of basal diameter in orthograde perfusion (n = 5) and 46±6.5% in retrograde perfusion (n = 5), while intraluminal addition of acetylcholine ( I0-5 M) reversed the diameter to 105±7.1% and 106±5.6% of basal values, respectively. When NE was given to Ef-Arts pretreated with L-NAME, the diameter decreased to 79±4.7% of baseline in orthograde perfusion (n = 6) and 63±12% in retrograde perfusion (n = 4), which remained unchanged after addition of acetylcholine (80±4.6% and 64±12%, respectively). (See Results and Discussion for weaker responses to NE in orthograde than in retrograde perfusion.) 6 . Effect ofL-NAME on NE-induced vasoconstriction. We examined whether L-NAME-induced enhancement of vasoconstrictor action is Since L-NAME not only augmented Ang II-induced vasoconstriction in Af-Arts but also reduced basal diameter (see Results), we tested whether L-NAME affected the action ofAng II by increasing basal tone. The experimental design was the same as in protocol 5, except that we used only Af-Arts and reduced basal diameter with I0-7 M NE instead of 10-4 M L-NAME.
Statistics
Values were expressed as mean±SEM, and all statistical analyses were done using absolute values. A paired t test was used to examine whether the diameter at a given concentration was different from the control value. Analysis of covariance (ANCOVA) was used to examine whether the change in diameter at a given concentration was different between groups. For both analyses, P < 0. Ef-Art diameter (1.4±0.33 Am or 9.5±2.3%; P < 0.01); however, it tended to be smaller than in the Af-Arts (P = 0.05). Moreover, with retrograde perfusion, L-NAME had no effect on Ef-Arts at any dose, and the decrease in diameter at l0-4 M was significantly different compared to the Af-Arts (P < 0.005).
Effect ofL-or D-arginine on L-NAME-induced constric-
tion. L-NAME pretreatment decreased Af-Art diameter from 18.5±0.7 to 14.8±0.7 (n = 6), while addition of L-arginine at l0-3 M reversed the diameter to control levels ( 19.4±1.1 Am).
On the other hand, D-arginine had no effect on the L-NAMEinduced decrease in diameter; with L-NAME, the diameter decreased from 18.7±0.7 to 15.0±0.8 Mm (n = 4) and remained unchanged after addition of D-arginine ( 14.4± 1.1 Mm).
5. Effect ofL-NAME on Ang II-induced vasoconstriction.
Changes in diameter induced by Ang II in L-NAME-treated and nontreated Af-Arts are depicted in Fig. 5 , while an example of the responses observed at 10-' M is shown in Fig. 6 . After L-NAME pretreatment, basal diameter decreased significantly by 22±5.6%, falling from 17.3±1.0 to 13.2±0.8 Mm (n = 9).
When Af-Arts were pretreated with L-NAME, Ang II at 10-10 M, which had no effect on nontreated Af-Arts, decreased the diameter significantly by 2.0±0.62 Mm or 14±4.0% (P < 0.012); at 10-" M, the diameter decreased by 1.9±0.66 Mm or 13±4.2%, but it did not reach statistical significance (P = 0.02). When compared to non-treated Af-Arts, the Ang IIinduced decrease in diameter was greater in the L-NAME-pretreated Af-Arts at doses of 10-", 10-10, and 10-' but not at 10-8 M.
In contrast, L-NAME pretreatment had no effect on Ef-Arts whether they were perfused in an orthograde or retrograde direction (Fig. 7) . Thus, with L-NAME pretreatment, Ang IT-induced constriction became no different in Af-Arts and Ef-Arts with orthograde perfusion. In the case of Ef-Arts with retrograde perfusion, constriction at 101`0, 10-9, and 10 8 M seemed to be greater compared to Af-Arts even with L-NAME pretreatment; however, the differences was not statistically sig-
6. Effect of L-NAME on NE-induced vasoconstriction. L-NAME pretreatment decreased luminal diameter by 25±3.4%, 2014 Ito et al. (Fig. 9 ).
Discussion
Differential sensitivity of the pre-and postglomerular arterial vessels to Ang II has been of great interest to many investigators. Using various experimental models, researchers have reported that sensitivity to Ang II is higher (3, 7, 13, 14) or exclusively present in the postglomerular vessels (2, 6, 15, 16), or similar in both vessels (17) (18) (19) (20) . To avoid neurohormonal and systemic hemodynamic influences, Edwards (6) developed an in vitro preparation consisting of an isolated rabbit We found striking differences in the vascular reactivity of Ef-Arts with orthograde versus retrograde perfusion. In retrograde perfusion, both Ang II-and NE-induced vasoconstriction were very strong, and the dose-response curves obtained were almost identical to those reported by Edwards (6) and Yuan et al. (7) in isolated but nonperfused Ef-Arts. On the other hand, vasoconstriction was much weaker in orthograde perfusion. Thus, when Ang II action on Af-Arts and Ef-Arts was compared, the difference was less marked (albeit significant) with orthograde than with retrograde perfusion of the Ef-Arts. The reason for the differences in Ef-Art reactivity is not clear. It has been reported that Ef-Art response to Ang II but not NE is pressure dependent (21 ) . However, we observed that not only the response to Ang II but also that to NE (which is pressure independent) were clearly different with orthograde versus retrograde perfusion. Furthermore, when we measured pressure in Ef-Arts studied with orthograde perfusion, it was found to be similar to that used for retrograde perfusion. The fact that L-NAME did not affect the differences in Ef-Art reactivity suggests that factors other than EDNO may be involved. It 50 .lm L-NAME (right). Note that L-NAME not only reduced basal diameter but augmented the vasoconstrictor action of angiotensin II.
In contrast to the difference in sensitivity to Ang II, NE has been reported to have a similar effect on isolated Af-Arts and Ef-Arts (6, 7) . Consistent with these studies, we found no difference in NE-induced vasoconstriction between Af-Arts and Ef-Arts with retrograde perfusion. However, in the Ef-Arts studied with orthograde perfusion, the decreases in diameter induced by higher concentrations (5 x 10'-and 10-6 M) were significantly less compared to either Af-Arts or Ef-Arts with retrograde perfusion. Weaker responses ofEf-Arts than Af-Arts to NE or electrical stimulation of renal nerves have also been observed in rat juxtamedullary nephrons (P. K. Carmines, personal communication) and the isolated perfused hydronephrotic kidney (25) . The fact that NE-induced constriction of EfArts is weaker or at best similar compared to Af-Arts suggests that the Ef-Art's higher sensitivity to Ang II is not due to either structural or physical factors, such as its thinner arteriolar wall or lower perfusion pressure. In fact, Yuan et al. (7) have shown that reducing intraluminal pressure ofthe Af-Art from 90 to 30 mmHg did not increase sensitivity to Ang II. They also reported that indomethacin had no effect on the Af-Art, suggesting that prostaglandins are not involved in the difference in sensitivity.
We have recently presented evidence that endogenous production ofEDNO is important in the control ofAf-Art reactivity (8) . We have shown that Ang II at l0-7 M causes only transient constriction of microperfused rabbit Af-Arts, which becomes stronger and more persistent when they are pretreated with L-NAME. These effects ofL-NAME are most likely due to inhibition of EDNO, since the present study has shown that L-arginine (the precursor of EDNO) but not D-arginine (an inactive isomer) reverses L-NAME-induced constriction ofthe Af-Art. We have now extended our previous findings, showing that L-NAME pretreatment increases sensitivity of the Af-Art to Ang II at more physiological concentrations. It is unlikely that this enhancement is due to the change in basal tone, since a similar reduction in basal diameter with NE had no effect on Ang II-induced vasoconstriction. In addition, L-NAME pretreatment did not alter Af-Art responses to NE, showing that enhancement of vasoconstriction by L-NAME is not common to all vasoconstrictors. On the other hand, L-NAME pretreatment had no effect on Ef-Art response to Ang II whether it was studied with orthograde or retrograde perfusion. Furthermore, we found that the L-NAME-induced decrease in basal luminal diameter is much smaller in Ef-Arts than in Af-Arts. These results suggest that in the Af-Art, endogenous EDNO not only controls basal tone but also counteracts the vasoconstrictor action of Ang II (but not NE), whereas it plays a minimal role in the Ef-Art. Thus the difference in sensitivity to Ang II O Nontreoted (n-u) * L-NAME (n-7) A Control (n-5) A L-NAME (n-6) 0 -1 -10 -9 -a Anglotenaln 11 (log Id) Figure 7 . Change in luminal diameter induced by Ang II in nontreated efferent arterioles (Nontreated) and efferent arterioles pretreated with L-NAME. Note that L-NAME had no effect in either orthograde or retrograde perfusion.
partially due to its significant interaction with EDNO in the Af-Art, compared to little, if any, interaction in the Ef-Art.
The reason why L-NAME had less effect on the Ef-Art than on the Af-Art is not clear. It is not likely to be due to insufficient blockade of EDNO synthesis, since L-NAME completely blocked acetylcholine-induced vasodilation in the Ef-Art. Neither is it likely to be due to arteriolar differences in the rate of diffusion of EDNO into underlying vascular smooth muscle cells nor their response to EDNO, since acetylcholine induces similar vasodilation in both Af-Arts and Ef-Arts (26) . However, there are several possibilities that could explain our observation. First, it may be that the basal (unstimulated) rate of EDNO synthesis was somehow higher and/or degradation lower in Af-Arts than in Ef-Arts. Second, there is experimental evidence that vascular smooth muscle cells of the Af-Art but not Ef-Art may possess voltage-dependent calcium channels (27, 28) , and that ENDO could directly hyperpolarize smooth muscle cells of some vessels independently of a putative endothelium-derived hyperpolarizing factor (29) . Thus, inhibition of EDNO with L-NAME may have altered membrane poten-0 o Nontreated (n-7) * L-NAME (n-B) Figure 8 . Change in luminal diameter induced by norepinephrine in nontreated afferent arterioles (Nontreated) and afferent arterioles pretreated with L-NAME. Note that L-NAME had no effect on NE-induced vasoconstriction, in marked contrast to enhanced Ang II action (Figs. 5  and 6 ). tial, preferentially affecting the Af-Art. Third, EDNO has been shown to modulate myogenic contraction (30) . Therefore, L-NAME may have potentiated myogenic tone in the Af-Art, but not in the Ef-Art which does not exhibit a myogenic response (6, 7) . Finally, EDNO have been shown to influence endothelial synthesis of vasoconstrictors such as endothelin (31) . Thus, it may be possible that L-NAME increased the level of vasoconstrictors significantly in the Af-Arts but not Ef-Arts. In our preparation ofAf-Arts, the action ofboth Ang II and endothelin (32) but not NE is augmented by L-NAME. However, the reason for such disparate effects of L-NAME is not clear. It has been proposed that cyclic GMP is involved in the intracellular mechanism of EDNO action (33) . It is possible that in the Af-Art, the mechanism ofthe vasoconstrictor action of both Ang II and endothelin is more susceptible to modulation by intracellular cyclic GMP than that of NE, so that a L-NAME-induced decrease in the basal level of cyclic GMP resulted in enhanced actions of Ang II and endothelin but not NE. It may also be that Ang II and endothelin stimulated EDNO synthesis more than NE under our experimental conditions. In addition, a recent preliminary report suggests that EDNO could displace bound endothelin from its receptors (34), raising the possibility that EDNO may have differential effects on Ang II and endothelin receptors versus NE receptors.
Several studies have recently examined the interaction between Ang II and EDNO in the systemic and renal circulation. De Nicola et al. (35) and Sigmon et al. (36) reported that in anesthetized rats intravenous L-NAME increased systemic blood pressure as well as systemic and renal vascular resistance. The increase in renal vascular resistance was greatly attenuated by either an Ang II antagonist or a converting-enzyme inhibitor (CEI), whereas systemic vascular resistance remained elevated, suggesting a unique interaction between Ang II and EDNO within the kidney. The study of De Nicola et al. (35) has further shown that the interaction takes place not only in the glomerular arterioles but also at the glomerular tuft and proximal tubule. In addition, an interaction between Ang II and EDNO has been shown to occur in the absence ofsystemic hemodynamic changes in conscious dogs (37) . These in vivo findings, taken together with our study strongly suggest that intrarenal EDNO plays an important role in the regulation of renal function by modulating the actions of Ang II. Norepinephrine (log M)
Clearance studies in the whole animal showed that acute inhibition of EDNO resulted in decreased renal blood flow with little change in the GFR, suggesting preferential constriction of the postglomerular vessel (Ef-Art) (38, 39) . Consistent with this observation, a micropuncture study by Zatz and de Nucci (40) showed that intravenous administration of L-NAME, which raised mean systemic blood pressure by 30 mmHg, decreased single-nephron plasma flow but had no effect on single-nephron GFR. These changes were associated with marked glomerular hypertension (73 mmHg in L-NAME-treated rats versus 50 mmHg in vehicle-treated rats), and calculation of regional vascular resistance indicated a preferential effect on the Ef-Art. Although these in vivo studies show the overall effects of EDNO inhibition, various changes in systemic hemodynamics, hormones and sympathetic nerve activity could have influenced the renal hemodynamic response.
In order to avoid systemic neurohormonal and hemodynamic influences, Radermacher et al. (41 ) employed a preparation of isolated rat kidney perfused with a synthetic solution at constant pressure. In this preparation, L-NAME decreased the GFR and increased the filtration fraction significantly, suggesting constriction of both Af-Arts and Ef-Arts. However, when red blood cells (which contain hemoglobin that scavenges EDNO) were added to the kidney perfusate, L-NAME caused a similar decrease in the GFR but no change in the filtration fraction, suggesting a predominant effect on the Af-Art. These authors speculated that when the kidneys were perfused with the hemoglobin-free solution, EDNO, which was produced only in the Af-Art and/or glomerulus, reached the Ef-Art through the lumen, whereas addition of red blood cells prevented EDNO from reaching the Ef-Art but not from acting on the luminal side in the Af-Art and/or glomerulus. This would explain why L-NAME increased vascular resistance in both Afand Ef-Arts in the synthetic solution, whereas it had no effect on Ef-Arts in the solution containing red blood cells. These observations are consistent with our study that L-NAME induced a small but significant constriction of the Ef-Art with orthograde perfusion, but had no effect when possible influences of the Af-Art and/or glomerulus was eliminated by perfusing the Ef-Art in a retrograde direction.
In contrast to our results showing the predominant effects of L-NAME on the Af-Art, L-NAME has been shown to produce similar decreases in the luminal diameter of both Af-Arts and Ef-Arts in rat juxtamedullary nephrons perfused with blood in vitro (42) . The decreases were markedly attenuated by pretreatment with either a converting-enzyme inhibitor or Ang II antagonist, suggesting interaction between endogenous Ang II and EDNO. However, L-NAME did not augment the vasoconstriction induced by exogenous Ang II, while the sensitivity of the Af-Art and Ef-Art to Ang II was the same in this preparation (17) (18) (19) . The reason for the discrepancies between these studies and ours is not clear, but may be related to the perfusion solution (synthetic solution versus blood) and/or the presence or absence of macula densa-mediated tubuloglomerular feedback. It may also be possible that in the juxtamedullary preparation, EDNO produced in the Af-Art and/or glomerulus somehow reached the Ef-Art at concentrations high enough to exert its action.
These and previous studies provide evidence that endogenous EDNO regulates Af-Art resistance by itself as well as by modulating the actions of both Ang II and endothelin (8, 32, 35, 37, (40) (41) (42) . Since the Af-Art is a site ofboth myogenic and tubuloglomerular feedback responses as well as renin synthesis and secretion (43) , alteration of EDNO in the Af-Art would have profound effects on glomerular and systemic hemodynamics, either directly or indirectly by altering renin release (9) . Indeed, recent experimental evidence suggests that EDNO may be involved (whether primarily or secondarily) in the altered renal hemodynamics seen in various pathological conditions such as hypertension and ischemic acute renal failure (44) . In spontaneously hypertensive rats at a phase of established but uncomplicated hypertension, inhibition of EDNO has been shown to cause exaggerated hypertension compared with their normotensive controls, Wistar-Kyoto rats (45) . We have previously shown that L-NAME decreases the luminal diameter ofmicroperfused Af-Arts to a greater degree in spontaneously hypertensive rats than in Wistar-Kyoto rats, suggesting that endogenous EDNO may be high (or intact) in SHR AfArts (46) . This activity of EDNO may help maintain glomerular filtration in the face of various structural and functional alterations that favor Af-Art contraction (47, 48) . On the other hand, EDNO appears to be low in ischemic acute renal failure (49) , which is characterized by profound diminution of the GFR that is disproportionate to the observed decrease in renal blood flow (50) . It is conceivable that low EDNO may cause a preferential increase in Af-Art resistance by itself as well as by augmenting the actions of various vasoconstrictors, such as Ang II and endothelin which are elevated in ischemic acute renal failure.
In conclusion, our observations clearly demonstrate that sensitivity to Ang II is higher in the isolated microperfused rabbit Ef-Art than in the Af-Art, whereas L-NAME, an inhibitor of EDNO synthesis, causes stronger vasoconstriction in the Af-Art than in the Ef-Art. Furthermore, L-NAME pretreatment augments the vasoconstrictor action of Ang II in the AfArt but not the Ef-Art. Thus endogenous EDNO would appear to modulate Ang II action in the Af-Art but not in the Ef-Art, which may contribute to the difference in sensitivity to Ang II.
